Niagen Bioscience (NAGE) Tax Provisions (2016 - 2026)
Niagen Bioscience's (NAGE) quarterly Tax Provisions came in at $417000.0 in Q1 2026, up 148.21% year-on-year from $168000.0 in Q1 2025, and up 42.81% on a QoQ basis from $292000.0 in Q4 2025.
Niagen Bioscience (NAGE) Tax Provisions (2016 - 2026) Analysis & Trends
Niagen Bioscience (NAGE) has 4 years of Tax Provisions data on file, last reported at $417000.0 in Q1 2026.
- On a quarterly basis, Tax Provisions rose 148.21% year-over-year to $417000.0 in Q1 2026; TTM through Mar 2026 was $1.1 million, a 123.89% increase from a year earlier, with the FY2025 full-year figure at $810000.0, up 165.57% from the prior year.
- Tax Provisions for Q1 2026 stood at $417000.0, up from $292000.0 in the prior quarter.
- Over the last five years, Tax Provisions for NAGE reached as high as $417000.0 in Q1 2026 and fell as low as $128000.0 in Q2 2025.
- Historically, Tax Provisions has averaged $255333.3 across 3 years, with a median of $257000.0 in 2025.
- Across the five-year window, Tax Provisions declined 4.26% in 2025 and soared 148.21% in 2026, its largest moves.
- Year by year, Tax Provisions stood at $305000.0 in 2024, then retreated by 4.26% to $292000.0 in 2025, then jumped by 42.81% to $417000.0 in 2026.
- Per Business Quant data, the three most recent Tax Provisions figures were $417000.0 in Q1 2026, $292000.0 in Q4 2025, and $222000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 125,146.46 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 31.86 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 188,883.60 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 221.50 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 104.00 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 179.00 Mn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Niagen Bioscience | 253.47 Mn | 186.92 Mn | 19.98 Mn | 417,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 417,000.00 |
| Dec 31, 2025 | 292,000.00 |
| Sep 30, 2025 | 222,000.00 |
| Jun 30, 2025 | 128,000.00 |
| Mar 31, 2025 | 168,000.00 |
| Dec 31, 2024 | 305,000.00 |
| Dec 31, 2016 | 3,500.00 |
| Oct 1, 2016 | 3,153.00 |
| Jul 2, 2016 | 4,087.00 |
| Apr 2, 2016 | -10,740.00 |
| Jan 2, 2016 | 4,527.00 |